Pharmachronicles

Top Menu

  • Home
  • Our Blog
  • Contact Us

Main Menu

  • Home Page
  • STUDENTS ZONE
  • Syllabus
  • Seminars & conferences
  • Online classes
    • Register
Sign in / Join

Login

Welcome! Login in to your account
Lost your password?

Lost Password

Back to login
  • Home
  • Our Blog
  • Contact Us

Pharmachronicles

Header Banner

Pharmachronicles

  • Home Page
  • STUDENTS ZONE
  • Syllabus
  • Seminars & conferences
  • Online classes
    • Register
  • UGC-Cancelled-List of journals

  • NAAC stops accepting applications for accreditation from pharmacy colleges

  • Pursuing MPhil/PhD while working as a teacher will effect experience: UGC

  • Public notice by government of india ministry of health and family welfare

Educational news
Home›Educational news›Will CRISPR a best way to fight against antibiotic resistant bacteria

Will CRISPR a best way to fight against antibiotic resistant bacteria

By admin
October 2, 2017
766
0
Share:

CRISPR (Clustered Regularly Interspaced Short Palindrome Repeats) is a family of DNA sequences in bacteria that contains fragment of DNA from viruses.
Several research works is going on genetically modified viruses that are efficient for bacteria to kill themselves could be the next step in fighting antibiotic-resistant infections.

Many companies have engineered such viruses, named as bacteriophages, to use the CRISPR gene-editing system to kill specific bacteria, according to a presentation at the CRISPR 2017 conference in Big Sky, Montana. These companies could begin clinical trials of therapies as soon as next year.
A French start-up company has urged the development of more powerful drugs to combat antibiotic-resistant diseases. With that in mind, the company called Eligo Bioscience has introduced a new kind of drug, Eligobiotics that are able to attack bacteria in a more focused way.
Taking Advantage of CRISPR
Possibly the most attractive thing about Eligobiotics is how it uses CRISPR the new method of gene editing to scan the bacteria and delivery precise cuts to its genetic code to wipe it out completely. In the past, CRISPR has been used to create crops, edit embryos to better understand human development, and could one day cure sickle-cell disease.
If everything goes well between trial in mice and eventual human trials Eligobiotics could be taken as a pill instead of an injection.
“This is a bit futuristic, but eventually we envision having a pill that will clean your microbiome daily,” Duportet said to Business Insider. “It’s the ultimate form of personalized medicine.”

TagsCRISPREligobiotics
Previous Article

Can a mutation makes the zika virus ...

Next Article

An innovative idea (Jerry the Bear) helps ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

admin

Related articles More from author

  • BLOGS

    Membrane vacuum cleaner as a new target for antibiotic resistance.

    October 18, 2017
    By admin
  • Educational news

    Govt Circular Released : Ph.D. Mandatory From 2021

    January 12, 2019
    By Sriram Nagarajan
  • Educational news

    Osmania University makes plagiarism checks a must for Ph.D thesis submissions

    July 14, 2018
    By Sriram Nagarajan
  • Educational news

    A new rule for global trails by Indian drug regulator

    October 16, 2017
    By admin
  • Educational newsPublications

    UGC-CARE List Group A ( UGC approved journals)

    October 2, 2019
    By admin
  • BLOGSEducational news

    Memory techniques for students

    November 15, 2018
    By admin

Leave a reply Cancel reply

You may interested

  • Phama news

    CARDIOVASCULAR DISORDERS HYPERTENSION

  • BLOGS

    Non immune engineered cells that can kill cancer cell upon contact

  • BLOGS

    CARDIOPROTECTIVE NATURE OF POMEGRANATE.

  • LATEST REVIEWS

  • TOP REVIEWS

  • Pharmacists are not eligible for certificate program of community health

    0
  • A New Class of Antimicrobials Has Just Been Found in Human Breast Milk Fresh super ...

    0

Timeline

  • May 24, 2021

    LIST OF SCOPUS INDEXED JOURNALS APRIL 2021

  • October 20, 2020

    List of UGC Approved journals 2020

  • June 8, 2020

    Brain Tumor Day -8th June – Endoscopic surgery: An innovative approach to treat brain tumour

  • June 4, 2020

    UGC-Cancelled-List of journals

  • June 1, 2020

    Saroj Group Of Hospitals restarts its complete operations – see major footfall in OPD consultation

Latest Comments

  • Sowmya V
    on
    December 13, 2019
    Nice keep it up

    Blood Test Might Predict Pregnancy Due Date and Preterm Birth

Find us on Facebook

Follow Us on Instagram

logo

Dui viverra Faucibus aliquet quis phasellus accumsan. Donec et facilisis sociosqu sed tortor elit eu aliquid turpis ridiculus.

Fly, shall, have greater fifth spirit midst under from stars thing is, had creepeth multiply kind. Man may they’re meat years have third bring replenish air two light deep fill.

About us

  • Dr.N.Sriram, Founder CEO, Pharmachronicles, HITS college of Pharmacy, Ghatkesar, Hyderabad, India
  • 9704361947
  • pharmachronicles@gmail.com
  • Recent

  • Popular

  • Comments

  • LIST OF SCOPUS INDEXED JOURNALS APRIL 2021

    By admin
    May 24, 2021
  • List of UGC Approved journals 2020

    By admin
    October 20, 2020
  • Brain Tumor Day -8th June – Endoscopic surgery: An innovative approach to treat brain tumour

    By Sriram Nagarajan
    June 8, 2020
  • UGC-Cancelled-List of journals

    By admin
    June 4, 2020
  • Blood Test Might Predict Pregnancy Due Date and Preterm Birth

    By Sundari srinidhi
    December 12, 2019
  • FDA is carefully evaluating prescription opioid medications approved to treat cough in children

    By admin
    July 16, 2015
  • Record Numbers of FDA‑Approved Drugs: Recent Trends

    By admin
    July 16, 2015
  • There make for Sixth that multiply blessed two divide creeping

    By admin
    July 16, 2015
  • Sowmya V
    on
    December 13, 2019

    Blood Test Might Predict Pregnancy Due Date and Preterm Birth

    Nice keep it up

Photostream

    Follow us

    • Contact
    • STUDENTS ZONE
    • About Us
    © Copyright Pharmachronicles. All rights reserved.